SavedAdd your journal

Journals / Erciyes Medical Journal / 2020 / Cilt: 42 - Sayı: 4

Effects of ABO/RhD Blood Types and HbA1c Levels on the Postoperative Cardiac Morbidity in Morbidly Obese Patients who Underwent Sleeve Gastrectomy

Özkan GÖRGÜLÜ
Mehmet Nuri KOŞAR
Pages
395–399
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, these findings of a retrospective cohort of morbidly obese patients who underwent sleeve gastrectomy revealed a significant positive weak correlation between high preoperative HbA1c levels and cardiac troponin levels in patients with postoperative cardiac complaints, while ABO/RhD blood type was not associated with preoperative HbA1c levels or the likelihood of postoperative cardiac complaints.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was designed to evaluate the impacts of high preoperative HbA1c levels and ABO and Rhesus D antigen (RhD) blood types on the risk of postoperative cardiac morbidity in morbidly obese patients who underwent sleeve gastrectomy.
📊
Key Findings & Data:Materials and Methods: In this retrospective study, 364 morbidly obese patients who underwent elective laparoscopic sleeve gastrectomy operation were included.
💡
Conclusion & Impact:Conclusion: In conclusion, these findings of a retrospective cohort of morbidly obese patients who underwent sleeve gastrectomy revealed a significant positive weak correlation between high preoperative HbA1c levels and cardiac troponin levels in patients with postoperative cardiac complaints, while ABO/RhD blood type was not associated with preoperative HbA1c levels or the likelihood of postoperative cardiac complaints.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study was designed to evaluate the impacts of high preoperative HbA1c levels and ABO and Rhesus D antigen (RhD) blood types on the risk of postoperative cardiac morbidity in morbidly obese patients who underwent sleeve gastrectomy. Materials and Methods: In this retrospective study, 364 morbidly obese patients who underwent elective laparoscopic sleeve gastrectomy operation were included. Data regarding patients’ demographics, preoperative HbA1c levels (low: 4–6%, high: >6%), ABO/RhD blood types, cardiac complaints within the first postoperative week and serum cardiac troponin levels (ng/mL) in patients with postoperative cardiac complaints were recorded. Results: The findings showed that HbA1c levels were >6.0% in 38.2% of the patients, blood type A (45.9%) was the most prevalent blood type, and postoperative cardiac symptoms were evident in 16.5% of patients. Patients with high and low HbA1c levels were similar concerning ABO/RhD blood type or rate of postoperative cardiac complaints. In patients with postoperative cardiac complaints, a significant positive weak correlation was noted with high troponin levels and high preoperative HbA1c levels (r=0.215, p=0.022). Conclusion: In conclusion, these findings of a retrospective cohort of morbidly obese patients who underwent sleeve gastrectomy revealed a significant positive weak correlation between high preoperative HbA1c levels and cardiac troponin levels in patients with postoperative cardiac complaints, while ABO/RhD blood type was not associated with preoperative HbA1c levels or the likelihood of postoperative cardiac complaints.

🔖

Cite This Article

GÖRGÜLÜ, Ö., KOŞAR, M. N. (2022). Effects of ABO/RhD Blood Types and HbA1c Levels on the Postoperative Cardiac Morbidity in Morbidly Obese Patients who Underwent Sleeve Gastrectomy. Erciyes Medical Journal, Cilt: 42 - Sayı: 4, 395–399. https://ajindex.com/articles/502310

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (N Y) 2017; 2(7): e17
  2. Zhou S, Welsby I. Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?. World J Cardiol 2014; 6(9): 985–92
  3. Meo SA, Rouq FA, Suraya F, Zaidi SZ. Association of ABO and Rh blood groups with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci 2016; 20(2): 237–42
  4. Chandra T, Gupta A. Association and Distribution of Hypertension, Obesity and ABO Blood groups in Blood Donors. Iran J Ped Hematol Oncol 2012; 2(4): 140–5
  5. Zakai NA, Judd SE, Alexander K, McClure LA, Kissela BM, Howard G, et al. ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study. J Thromb Haemost 2014; 12(4): 564–70
  6. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32(9): 2314–20
  7. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010; 19(9): 1856–62
  8. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377(9763): 383–92
  9. Astarcıoğlu MA, Kalçık M, Yesin M, Gürsoy MO, Şen T, Karakoyun S, et al. AB0 blood types: impact on development of prosthetic mechanical valve thrombosis. Anatol J Cardiol 2016; 16(11): 820–3
  10. Garrison RJ, Havlik RJ, Harris RB, Feinleib M, Kannel WB, Padgett SJ. ABO blood group and cardiovacular disease: the Framingham study. Atherosclerosis 1976; 25(2-3): 311–8
  11. Clark P, Meiklejohn DJ, O’Sullivan A, Vickers MA, Greaves M. The relationships of ABO, Lewis and Secretor blood groups with cerebral ischaemia of arterial origin. J Thromb Haemost 2005; 3(9): 2105–8
  12. Hitsumoto T. Factors Associated with High-sensitivity Cardiac Troponin T in Patients with Type 2 Diabetes Mellitus. J Nippon Med Sch 2015; 82(6): 274–80
  13. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005; 165(16): 1910–6
  14. Wallace TW,